THE PROGNOSTIC ROLE OF PRE-TREATMENT PLATELET-TO-LYMPHOCYTE RATIO IN HEAD AND NECK SQUAMOUS CELL CARCINOMA: META-ANALYSIS AND TRIAL SEQUENTIAL ANALYSIS
Journal of Evidence-Based Dental Practice · 2023
DOI: 10.1016/j.jebdp.2023.101898 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Evidence-Based Dental Practice, 2023. Verfasst von Russo Diana und 5 weiteren Autor:innen. Beteiligte Einrichtung: Multidisciplinary Department of Medical-Surgical and Odontostomatological Specialties, University of Campania "Luigi Vanvitelli", Naples, Italy. Elec…. Hauptthemen laut MEDLINE: Lymphocytes, Head and Neck Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 50 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Evidence suggests that inflammation contributes to tumor development, from onset to progression and metastasis. Platelet-to-lymphocyte ratio (PLR) is a composite parameter that provides information from two distinct cellular elements, platelets, and lymphocytes. The purpose of this systematic review and meta-analysis is to evaluate the prognostic role of the PLR, in terms of overall survival (OS), disease-free survival (DFS), cancer-specific survival (CSS) and progression-free survival (PFS), in patients with primary head and neck squamous cell carcinoma treated with surgery followed or not by adjuvant therapies. MATERIALS AND METHODS: This systematic review was performed according to the guidelines reported in the Cochrane Handbook and the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) statement. Meta-analysis of OS and DFS was performed using the inverse of variance test. Random-effect models were used on the basis of high heterogeneity. Risk of bias assessment, quality of evidence within studies (GRADE) and trial sequential analysis (TSA) were also performed. RESULTS: The analysis revealed that a higher value of pretreatment PLR correlates with a statistically significant decrease of OS (HR, 1.85; 95% CI: [1.23, 2.80]; P < .00001), confirmed by TSA. The meta-analysis reports an association between high PLR and DFS (HR,1.46; 95% CI: [1.03, 2.06]; P = .003); but TSA suggests that it his should be considered as a false positive. Further studies are needed to validate the efficacy of PLR in predicting CSS and PFS outcomes. CONCLUSION: Pretreatment PLR is an independent prognostic factor for OS in HNSCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Multidisciplinary Department of Medical-Surgical and Odontostomatological Specialties, University of Campania "Luigi Vanvitelli", Naples, Italy. Electronic address: dianarusso96@gmail.com.
- Multidisciplinary Department of Medical-Surgical and Odontostomatological Specialties, University of Campania "Luigi Vanvitelli", Naples, Italy.
- Department of Mental, Physical Health, and Rehabilitation Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.
Zitieren
APA
Diana, R., Pierluigi, M., Dardo, M., Claudia, A., Rosario, R., & Luigi, L. (2023). THE PROGNOSTIC ROLE OF PRE-TREATMENT PLATELET-TO-LYMPHOCYTE RATIO IN HEAD AND NECK SQUAMOUS CELL CARCINOMA: META-ANALYSIS AND TRIAL SEQUENTIAL ANALYSIS. Journal of Evidence-Based Dental Practice. https://doi.org/10.1016/j.jebdp.2023.101898
Vancouver
Diana R, Pierluigi M, Dardo M, Claudia A, Rosario R, Luigi L. THE PROGNOSTIC ROLE OF PRE-TREATMENT PLATELET-TO-LYMPHOCYTE RATIO IN HEAD AND NECK SQUAMOUS CELL CARCINOMA: META-ANALYSIS AND TRIAL SEQUENTIAL ANALYSIS. Journal of Evidence-Based Dental Practice. 2023. doi:10.1016/j.jebdp.2023.101898
BibTeX
@article{Diana2023,
author = {Diana, Russo and Pierluigi, Mariani and Dardo, Menditti and Claudia, Arena and Rosario, Rullo and Luigi, Laino},
title = {THE PROGNOSTIC ROLE OF PRE-TREATMENT PLATELET-TO-LYMPHOCYTE RATIO IN HEAD AND NECK SQUAMOUS CELL CARCINOMA: META-ANALYSIS AND TRIAL SEQUENTIAL ANALYSIS},
journal = {Journal of Evidence-Based Dental Practice},
year = {2023},
doi = {10.1016/j.jebdp.2023.101898}
}
EUVIMED